Neuro-Oncologist Benjamin Purow, MD
Joins Parabon's Advisory Board

14 June 2010

Parabon NanoLabs is pleased to announce that Benjamin Purow, MD has joined the company's scientific advisory board. Dr. Purow received his B.A. in Chemistry and Physics cum laude from Harvard University in 1991 and his M.D. from Johns Hopkins Medical School in 1996. From 1994-1995, he was a Howard Hughes Medical Institute (HHMI) Medical Student Fellow in the laboratory of Hyam Levitsky at Johns Hopkins. Dr. Purow completed a residency in pediatrics at Children's National Medical Center in Washington, DC, followed by fellowship training in pediatric hematology/oncology and in neuro-oncology at the NIH. Dr. Purow spent several years pursuing brain tumor research in the laboratory of Howard Fine at the NIH, during which he was the first to show a role for the Notch pathway in gliomas. He obtained his first independent position in 2006 as an Assistant Professor in neuro-oncology at the University of Virginia in Charlottesville. Dr. Purow spends 75-80% of his time leading his laboratory and 20-25% in clinical care of patients with brain tumors. His research is focused on the Notch pathway and microRNAs in gliomas, with the ultimate goal of developing new therapies for these lethal cancers. In 2008 Dr. Purow received an HHMI Physician-Scientist Early Career Award, as well as two five-year NIH R01 awards.

- - - - -

For more information contact, 703.689.9689 x250